World's Best Scientists 2026 revealed!
VIEW LIST
Mark R. Litzow

Mark R. Litzow

Mayo Clinic
United States

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 123 3356 3131 1844 1698 1016 55915

Mark R. Litzow publications per year

The chart shows the history of publications by Mark R. Litzow between 1989 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Mark R. Litzow published across 38 years, from 1989 to 2026, averaging 36.6 papers a year. Output peaked at 148 publications in 2023. 53 of the 1,392 publications appeared in the last two years.

No. of publications
25 50 75 100 125
Bar chart. Horizontal axis: year, 1989 to 2026. Vertical axis: number of publications, 0 to 148. Peak 148 publications in 2023. 1989: 1 publication 1990: 0 publications 1991: 1 publication 1992: 2 publications 1993: 0 publications 1994: 1 publication 1995: 1 publication 1996: 0 publications 1997: 6 publications 1998: 3 publications 1999: 6 publications 2000: 11 publications 2001: 14 publications 2002: 11 publications 2003: 12 publications 2004: 27 publications 2005: 33 publications 2006: 25 publications 2007: 28 publications 2008: 44 publications 2009: 27 publications 2010: 38 publications 2011: 38 publications 2012: 41 publications 2013: 49 publications 2014: 46 publications 2015: 78 publications 2016: 77 publications 2017: 76 publications 2018: 72 publications 2019: 75 publications 2020: 74 publications 2021: 96 publications 2022: 105 publications 2023: 148 publications 2024: 73 publications 2025: 52 publications 2026: 1 publication
1989 2026

1,392 publications in total across all disciplines

View publications per year as a table
Mark R. Litzow: publications per year, 1989 to 2026
Year Publications
1989 1
1990 0
1991 1
1992 2
1993 0
1994 1
1995 1
1996 0
1997 6
1998 3
1999 6
2000 11
2001 14
2002 11
2003 12
2004 27
2005 33
2006 25
2007 28
2008 44
2009 27
2010 38
2011 38
2012 41
2013 49
2014 46
2015 78
2016 77
2017 76
2018 72
2019 75
2020 74
2021 96
2022 105
2023 148
2024 73
2025 52
2026 1
Total 1,392
Download as CSV

Mark R. Litzow publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark R. Litzow sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,001–1,020 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,016 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77 1,016
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Mark R. Litzow D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark R. Litzow sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 122–123 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 123 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255 123
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Mark R. Litzow is affiliated with the Mayo Clinic in the United States and has a significant research footprint in the field of medicine, particularly within hematology. Their research encompasses various subfields, including genetics, public health, environmental and occupational health, molecular biology, and oncology.

The main topics of Mark R. Litzow's work include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation
  • Chronic Lymphocytic Leukemia Research
  • CAR-T Cell Therapy Research

Mark R. Litzow has contributed to publications in several key venues. The most frequent publication venues include:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • American Journal of Hematology
  • Blood Cancer Journal

Some notable recent papers featuring Mark R. Litzow include:

  • Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, 2021, Journal of the National Comprehensive Cancer Network
  • Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial, 2022, Blood
  • Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial, 2020, Nature Medicine
  • American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults, 2020, Blood Advances
  • Palliative Care for Patients With Cancer: ASCO Guideline Update, 2024, Journal of Clinical Oncology

Frequent co-authors who have collaborated extensively with Mark R. Litzow include:

  • Hassan B. Alkhateeb
  • William J. Hogan
  • Mrinal M. Patnaik
  • Mithun Vinod Shah
  • Aref Al-Kali

Best Publications

  • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

    Jay P. Patel;Mithat Gönen;Maria E. Figueroa;Hugo Fernandez

  • Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

    Max S. Topp;Nicola Gökbuget;Anthony S. Stein;Gerhard Zugmaier

  • MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

    Animesh D. Pardanani;Ross L. Levine;Terra Lasho;Yana Pikman

  • Anthracycline Dose Intensification in Acute Myeloid Leukemia

    Hugo F. Fernandez;Zhuoxin Sun;Xiaopan Yao;Mark R. Litzow

  • Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

    Hagop M. Kantarjian;Francis Giles;Norbert Gattermann;Kapil Bhalla

  • In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

    Anthony H. Goldstone;Susan M. Richards;Hilliard M. Lazarus;Martin S. Tallman

  • Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

    Jennifer A Woyach;Amy S Ruppert;Nyla A Heerema;Weiqiang Zhao

  • Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

    Adele K. Fielding;Susan M. Richards;Rajesh Chopra;Hillard M. Lazarus

  • Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

    Jacob M. Rowe;Georgina Buck;Alan Kenneth Burnett;Raj Chopra

  • Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

    Voravit Ratanatharathorn;Richard A. Nash;Donna Przepiorka;Steven M. Devine

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

    Tait D. Shanafelt;Xin V. Wang;Neil E. Kay;Curtis A. Hanson

  • International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

    Andrew C. Harris;Andrew C. Harris;Rachel Young;Rachel Young;Steven Devine;William J. Hogan

  • First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

    Paul J. Martin;J. Douglas Rizzo;John R. Wingard;Karen Ballen

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

    Anthony V. Moorman;Christine J. Harrison;Georgina A.N. Buck;Sue M. Richards

  • Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure

    Michel Duval;John P. Klein;Wensheng He;Jean Yves Cahn

  • Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

    Alexander E. Perl;Jessica K. Altman;Jorge Cortes;Catherine Smith

  • Hematologic manifestations of celiac disease.

    Thorvardur R. Halfdanarson;Mark R. Litzow;Joseph A. Murray

  • Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

    Morie A. Gertz;Martha Q. Lacy;Angela Dispenzieri;Philip R. Greipp

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia

    A Moorman;C J Harrison;Buck Gan.;S M Richards

Frequent Co-Authors

Mrinal M. Patnaik
Mrinal M. Patnaik Mayo Clinic
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Morie A. Gertz
Morie A. Gertz Mayo Clinic
Martha Q. Lacy
Martha Q. Lacy Mayo Clinic
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Martin S. Tallman
Martin S. Tallman Northwestern University
Angela Dispenzieri
Angela Dispenzieri Mayo Clinic
Rhett P. Ketterling
Rhett P. Ketterling Mayo Clinic
Animesh Pardanani
Animesh Pardanani Mayo Clinic
David J. Inwards
David J. Inwards Mayo Clinic

External Links

Personal website of Mark R. Litzow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are many online programs designed to support individuals pursuing medical and healthcare careers in the USA. As demand grows for skilled healthcare professionals, online degrees offer flexibility and affordability for students balancing work, family, or other commitments. Specializing in health administration, pharmacy, nursing, or information management can open up new pathways within the healthcare sector.

For those interested in administrative roles, the cheapest online mha programs can help you gain leadership and management skills essential for running healthcare facilities. If advanced nursing is your interest, you might consider the cheapest dnp programs to pursue your Doctor of Nursing Practice online at a lower cost.

Aspiring pharmacists can explore the cheapest online pharmacy school options, which prepare graduates for vital roles in medication management and patient care. Additionally, technology-focused students can opt for online rhit degree programs to enter the high-demand field of health information management.

Choosing the right online degree not only keeps costs down but also broadens your career opportunities, allowing you to make a meaningful impact in healthcare.

Best Scientists Citing Mark R. Litzow

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 355

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 239

Elias Jabbour

Elias Jabbour

The University of Texas MD Anderson Cancer Center

Publications: 205

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 187

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 177

Farhad Ravandi

Farhad Ravandi

The University of Texas MD Anderson Cancer Center

Publications: 175

Mohamad Mohty

Mohamad Mohty

Inserm

Publications: 166

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 157

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 144

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 136

Ayalew Tefferi

Ayalew Tefferi

Mayo Clinic

Publications: 131

Ruben A. Mesa

Ruben A. Mesa

The University of Texas Health Science Center at San Antonio

Publications: 130

Guillermo Garcia-Manero

Guillermo Garcia-Manero

The University of Texas MD Anderson Cancer Center

Publications: 123

Xiao-Jun Huang

Xiao-Jun Huang

Peking University

Publications: 121

Srdan Verstovsek

Srdan Verstovsek

The University of Texas MD Anderson Cancer Center

Publications: 119

Susan O'Brien

Susan O'Brien

University of California, Irvine

Publications: 114

Trending Scientists

Tirumalai S. Srivatsan

Tirumalai S. Srivatsan

University of Akron

Yiu-Wing Mai

Yiu-Wing Mai

Hong Kong Polytechnic University

Jun Yeob Lee

Jun Yeob Lee

Sungkyunkwan University

Jacqueline N. Crawley

Jacqueline N. Crawley

University of California, Davis

Chenguang Yang

Chenguang Yang

University of Liverpool

Bernard Weiner

Bernard Weiner

University of California, Los Angeles

Xian Xue

Xian Xue

Chinese Academy of Sciences

David Copp

David Copp

University of California, Davis

Howard H. Goldman

Howard H. Goldman

University of Maryland, College Park

Chiara Agrati

Chiara Agrati

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

William P. Marnane

William P. Marnane

University College Cork

Stephen Faulkner

Stephen Faulkner

University of Oxford

Carmen Nájera

Carmen Nájera

University of Alicante

Gary W. Miller

Gary W. Miller

Columbia University

Jens Ove Andreasen

Jens Ove Andreasen

Copenhagen University Hospital

Nicholas J. Gotelli

Nicholas J. Gotelli

University of Vermont

Related Medicine Rankings & Guides

2027 Easiest Nurse Midwife Programs to Get Into

2027 Easiest Nurse Midwife Programs to Get Into
2027 Easiest Direct-Entry MSN Programs to Get Into

2027 Easiest Direct-Entry MSN Programs to Get Into
2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate

2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate
2027 Fastest Online BSN to MSN Bridge Programs

2027 Fastest Online BSN to MSN Bridge Programs
2027 Easiest RN-to-BSN Online Programs

2027 Easiest RN-to-BSN Online Programs
2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus
2027 Most Affordable Online BSN to DNP Degree Programs

2027 Most Affordable Online BSN to DNP Degree Programs
2027 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs
2027 Best Online Respiratory Therapy Programs

2027 Best Online Respiratory Therapy Programs
2027 Best One-Year Online PMHNP Programs

2027 Best One-Year Online PMHNP Programs
2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus
2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs
2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus
2027 Best Online Adult-Gerontology ACNP Graduate Certificate Programs

2027 Best Online Adult-Gerontology ACNP Graduate Certificate Programs
2027 Best Online Sonography Programs

2027 Best Online Sonography Programs
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus
2027 Best Online Exercise Science Degree Programs

2027 Best Online Exercise Science Degree Programs
2027 Most Affordable Online FNP Programs

2027 Most Affordable Online FNP Programs
2027 How Much Do Medical Assistant Programs & Certifications Cost?

2027 How Much Do Medical Assistant Programs & Certifications Cost?
2027 Fastest Online Master's Degree in Healthcare Management Programs

2027 Fastest Online Master's Degree in Healthcare Management Programs
2027 Best Online Dual FNP/PMHNP Degree Programs

2027 Best Online Dual FNP/PMHNP Degree Programs

Recently Published Articles

2027 Fastest Online MBA Programs in Environmental Management

2027 Fastest Online MBA Programs in Environmental Management
2027 Forensic Science Degree Careers: Skills, Education, Salary & Job Outlook

2027 Forensic Science Degree Careers: Skills, Education, Salary & Job Outlook
2027 What Prerequisites Do You Need for a Bioinformatics Master's Degree? Entry Requirements, Credits & Eligibility Rules

2027 What Prerequisites Do You Need for a Bioinformatics Master's Degree? Entry Requirements, Credits & Eligibility Rules
2027 Micro, Mezzo, Macro Social Work: Definitions, Differences & Levels

2027 Micro, Mezzo, Macro Social Work: Definitions, Differences & Levels
2027 Nurse Practitioner Subspecialty Certification

2027 Nurse Practitioner Subspecialty Certification
2027 Online Cybersecurity Degrees With the Best FAFSA-Friendly Options

2027 Online Cybersecurity Degrees With the Best FAFSA-Friendly Options
2027 How to Become a Nurse Midwife in Ohio – Midwife Schooling Requirements

2027 How to Become a Nurse Midwife in Ohio – Midwife Schooling Requirements
2027 How to Become a High School History Teacher in Indiana: Requirements & Certification

2027 How to Become a High School History Teacher in Indiana: Requirements & Certification
2027 Best BSN to MSN Programs in Georgia: Online & Campus

2027 Best BSN to MSN Programs in Georgia: Online & Campus
2027 Self-Paced Online Finance Bachelor's Degree Programs

2027 Self-Paced Online Finance Bachelor's Degree Programs
2027 Best Online Entertainment Business Degree Master's Programs for Working Professionals

2027 Best Online Entertainment Business Degree Master's Programs for Working Professionals
2027 Best Online Master’s in Curriculum and Instruction Programs

2027 Best Online Master’s in Curriculum and Instruction Programs
2027 Best Online Forensic Psychology Degree Master's Programs for Working Professionals

2027 Best Online Forensic Psychology Degree Master's Programs for Working Professionals
2027 How to Become a Licensed Pharmacist in Denver, CO: License Requirements

2027 How to Become a Licensed Pharmacist in Denver, CO: License Requirements
2027 Best Online Forensic Accounting Degree Programs

2027 Best Online Forensic Accounting Degree Programs
2027 Best Homeland Security Degree Programs

2027 Best Homeland Security Degree Programs
2027 Accredited Online Special Education Degree Master's Programs: How to Verify & Avoid Scams

2027 Accredited Online Special Education Degree Master's Programs: How to Verify & Avoid Scams
2027 Forensic Psychology Degree Levels Explained: Bachelor's vs Master's vs Doctorate

2027 Forensic Psychology Degree Levels Explained: Bachelor's vs Master's vs Doctorate
2027 How Long Does It Take to Earn an Online Administration Degree?

2027 How Long Does It Take to Earn an Online Administration Degree?
2027 Best Online DNP Nurse Educator Programs

2027 Best Online DNP Nurse Educator Programs
2027 Best Online TESOL Degree Master's Programs for Working Professionals

2027 Best Online TESOL Degree Master's Programs for Working Professionals